基本資料
種類: ETF
費用比率%: 1.46
資產淨值: 13.16
成立日期: 26/06/2015
 
分析
市值分佈:
59.08%
大市值
10.88%
中市值
8.50%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 05/09/2026 05:54) 總持有投資項目: 58  
0%
 
100%
     10大 (29.18%)
代號 名稱 佔比% ▼ 持有日期
ABVXAbivax SA3.5031/07/2026
MANEVeradermics Inc3.4630/06/2026
QUREuniQure NV3.2731/07/2026
SNYSanofi ADS2.9230/06/2026
MDTMedtronic plc2.7131/07/2026
NVONovo-Nordisk A/S2.3031/07/2026
RHHBYRoche Holding Ltd2.2931/07/2026
DHRDanaher Corp1.9731/07/2026
OXBDFOxford Biomedica PLC1.7830/06/2026
NAMSNewAmsterdam Pharma Company NV1.6831/07/2026
ISRGIntuitive Surgical1.6631/07/2026
MRKMerck & Co1.6331/07/2026
PRQRProQR Therapeutics NV1.6231/07/2026
WELLWelltower1.4131/07/2026
GPCRStructure Therapeutics1.3830/06/2026
LZAGFLonza Group AG1.3231/07/2026
DTILPrecision BioSciences1.2031/07/2026
BAYZFBayer A.G.1.1731/07/2026
CRLCharles River Laboratories International1.1731/07/2026
HUMHumana1.0331/07/2026
 1    2    3  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.